期刊文献+

地方高值罕见病用药保障的实施经验与启示 被引量:3

Experience and Enlightenment of High Value Orphan Drugs Security Mechanism in Local
下载PDF
导出
摘要 在我国,大多数罕见病患者群体依旧面临着诊治困难、用药负担重等难题。随着社会对罕见病患者群体关注度的不断上升,国家层面虽然未出台罕见病专项法律法规,但已有部分省市先行试点,探索罕见病用药保障机制。本研究在佛山、广州两地展开调研,发现佛山市形成了包含“平安佛医保”和医疗救助等多层次罕见病医疗保障体系;广州市的补充型商业医疗保险“穗岁康”对罕见病患者的保障力度更加。通过深入分析两地罕见病用药保障机制的特点、实施效果等,总结实施经验,提出建议,为我国制定罕见病相关政策提供良好借鉴。 In China,most patients with rare diseases still face the problems of difficult diagnosis and treatment,heavy medication burden etc.As the society′s attention to rare diseases as a special group continue to rise,although the national level has not issued special laws and regulations on rare diseases,various provinces and cities have already piloted trials to explore the drug protection mechanism for rare diseases.In the investigation of Foshan and Guangzhou,our research team found that Foshan has formed a multi-level medical security system for rare diseases,including"Pinganfo medical insurance"and medical assistance;Guangzhou′s supplementary commercial medical insurance"suisuisuisuikang"is more advanced in protecting patients of rare diseases.In this paper,through in-depth analysis of the content,characteristics and implementation effect of the drug security mechanism of rare diseases in both places,and putting forward corresponding improvement suggestions,hoping that these experiences can provide good references for the country and other provinces to formulate policies related to rare diseases.
作者 韩朦 兰娅菲 张朦 高子雯 褚淑贞 HAN Meng;LAN Ya-fei;ZHANG Meng;GAO Zi-wen;CHU Shu-zhen(Research Center of National Drug Policy&Ecosystem,China Pharmaceutical University,Nanjing Jiangsu 211198,China)
出处 《中国药物评价》 2022年第4期345-350,共6页 Chinese Journal of Drug Evaluation
关键词 罕见病 用药保障 佛山 广州 Rare diseases Drug protection mechanism Foshan Guangzhou
  • 相关文献

参考文献7

二级参考文献46

  • 1龚时薇,张敏,邓秀玲,何惠君,李燕,王祎.对我国罕见病与罕用药界定的思考[J].中国新药杂志,2006,15(15):1225-1229. 被引量:20
  • 2张国英,张双雨.大病、特殊疾病医疗保险费用的支付途径[J].中国医院管理,2007,27(7):67-67. 被引量:10
  • 3KE Xu.Designing Health Financing To Reduce Catastrophic Health Expentdiure.[EB/OL]http://www.WHO/EIP/HSF/PB/05.02. 被引量:1
  • 4KE Xu.Household catastrophic health expenditure:a multicountry analysis[J].THE LANCET,2003,362(7):111-117. 被引量:1
  • 5Alison Abbott. Rare - disease project has global ambi?tions[J] . Nature, 2011, (472): 17. 被引量:1
  • 6Wills Hughes - Wilson, Ana Palma, Ad Schuurman and Steven Simoens, Paying for the orphan drug system: break or bend? Is it time for a new evaluation system for payers in Eu?rope to take account of new rare disease treatments?[J]. Or?phanetJournal of Rare Diseases, 2012 ( 7) : 74. 被引量:1
  • 7李定国专访.中国医学论坛报,2013年3月28日A9版. 被引量:1
  • 8刘轶琳,陈晓琪,曹子琛.委员连续4年为罕见病交提案不放弃救千分之一[EB].检索自http://gongyi.qq.eorrt/a/20120309/000001.htm,2012年3月8日发表/2013年9月30日检索引用. 被引量:1
  • 9左佰常,浙江政协委员提案呼吁:建立"罕见病"防治保障制度[EB].检索自http://health.zj01.conl.en/05zjhealth/system/2013/02/27/019175117.shtml,2013年2月28日发/2013年9月30日检索引用. 被引量:1
  • 10Wills Hughes - Wilson, Ana Palma, Ad Schuurman and Steven Simoens, Paying for the orphan drug system: break or bend? Is it time for a new evaluation system for payers in Eu?rope to take account of new rare disease treatments?[J]. Or?phanetJournal of Rare Diseases, 2012(7) :74. 被引量:1

共引文献53

同被引文献66

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部